Devon-based Zynerba Pharmaceuticals Added to Russell 2000® and 3000® Indexes
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced the Company’s addition as a member of the U.S. …
Read More